aTyr Pharma | LIFE - Selling And Administration Expenses


aTyr Pharma reported $635.82K in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Alterity Therapeutics Limited AUD 1.45M 703.96K Dec/2025
Ardelyx USD 101.44M 827K Jun/2026
aTyr Pharma USD 635.82K 64.81K Jun/2026
Biogen USD 752M 42.3M Sep/2026
Bristol-Myers Squibb USD 1.7B 127M Sep/2026
Cipla INR 13.25B 101.8M Dec/2025
Clal Biotechnology ILS 3.31M 513K Dec/2022
Compugen USD 2.44M 5K Jun/2026
CSL USD 1.23B 498M Dec/2025
Curis USD 2.96M 1.62M Mar/2026
GlaxoSmithKline GBP 2.16B 39M Sep/2026
Grifols EUR 320.45M 12.65M Dec/2025
Lakefront Biotherapeutics EUR 22.5M 13M Jun/2026
Novartis USD 3.08B 163M Sep/2026
Roche Holding CHF 6.37B 908M Jun/2026
United Therapeutics USD 184.1M 22.6M Sep/2026